MedTrace Logo

Development of a Pain Rehabilitation Program for Chronic Pain After SCI

NCT07634796 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-06-09

No results posted yet for this study

Summary

Pain rehabilitation programs are essential for optimal treatment of chronic pain and are usually based on the biopsychosocial model. This is, however, not standard care for people with chronic pain after a spinal cord injury (SCI) due to a biomedical focused perspective of SCI and lack of adapted programs.

The aims of this feasibility study:

1. Develop a new digital pain rehabilitation program, adapted for the needs of people living with an SCI.
2. To investigate the feasibility and acceptability of a new digital pain rehabilitation program.

Conditions

  • Spinal Cord Injuries
  • Chronic Pain
  • Neuropathic Pain
  • Interprofessional Team Collaboration
  • Pain Management

Interventions

OTHER

multi-modality pain management

8- week pain rehabilitation program. The first meeting of the program is located at a hospital facility and thereafter they will meet at a digital platform.The program include education, home exercises and group meetings. The program consists of 4 modules. 1. Physical exercise and ergonomics. 2. Structure and recovery. 3. Employment/occupation and social support. 4. ACT and coping. Each module lasts for two weeks. The program will include video material for education, home exercises and group discussions led by clinicians with long experience in pain rehabilitation and SCI.

Sponsors & Collaborators

  • Region Västerbotten

    collaborator OTHER_GOV

  • Riksförbundet för Trafik, Olycksfall och Polioskadade (RTP), Sundbyberg, Sweden

    collaborator UNKNOWN

  • Norrbacka-Eugenia Foundation

    collaborator OTHER

  • Promobilia Foundation

    collaborator OTHER

  • Umeå University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-01
Primary Completion
2027-09-30
Completion
2027-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07634796 on ClinicalTrials.gov